NEURACEQ

Описание товара

About NEURACEQ

NEURACEQ is a diagnostic imaging agent used in positron emission tomography (PET) scans to visualize and assess the brain's amyloid plaques, which are associated with Alzheimer's disease. It contains the active ingredient Florbetaben (18F), a radioactive tracer that binds to amyloid beta peptides in the brain.

Key Benefits & Uses

• Visualizes amyloid plaques in the brain, aiding in the diagnosis of Alzheimer's disease
• Helps assess the extent of amyloid deposition in the brain
• Supports the evaluation of treatment efficacy in Alzheimer's disease

Active Ingredient & Action

Florbetaben (18F) is a radiolabeled derivative of florbetaben, a beta-amyloid binding ligand. It selectively binds to amyloid beta peptides in the brain, allowing for the visualization of amyloid plaques in PET scans. This enables clinicians to assess the presence and extent of amyloid deposition, which is a hallmark of Alzheimer's disease.

Important Notes

NEURACEQ is a prescription medication that should only be administered by a qualified healthcare professional. It is essential to follow the recommended dosing and administration guidelines to ensure safe and effective use. Patients should be informed about the potential risks and benefits associated with the use of NEURACEQ, including radiation exposure and potential allergic reactions.